Completed

NCT Number: NCT02285127

Short Versus Long Cephalomedullary Nailing of Pertrochanteric Hip Fractures: A Randomized Prospective Study

Is there a functional outcome difference when treating pertrochanteric fractures with a short or long cephalomedullary nail?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pertrochanteric Hip Fracture

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

AO/OTA fracture classification 31(A-B) (1-3).
Age greater than 18 years old.

Exclusion criteria

-Less than 18 years old.

Treatment and study plan

Short versus long cephalomedullary Intramedullary nail

Procedure

Biomet Affixus Short and Long hip fracture nail. Stryker Gamma Short and Long hip fracture nail.

Primary outcomes

SF (short form)-36

Time frame: 3 months

Secondary outcomes

Harris Hip Score

Time frame: 3 months

Other outcomes

Reoperation

Time frame: within 1 year
Mortality

Time frame: 1 year

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start: 2014
Primary completion: 2018
Study completion: 2019
First posted: Nov 6, 2014
Registry last updated: May 12, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.